Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

NCT06753994 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Type1diabetes
T1D

Interventions

DRUG: SGLT-2 inhibitor

Sponsor

McGill University